Clinical Trial Update: Safety and Superiority of Penicillamine in Radiosensitization of Recurrent Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update investigating safety and potential superiority of penicillamine as a radiosensitizer for recurrent head and neck cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Penicillamine (Penicillamine)

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Head and Neck Cancer, Recurrent Cancer | Phase 2 | Status: UNKNOWN